Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The branched-chain amino acid (BCAA) metabolism pathway refers to the series of biochemical processes responsible for the catabolism and regulation of three essential amino acids: leucine, isoleucine, and valine. This pathway is vital for protein synthesis, energy production, metabolic homeostasis, and signaling in various tissues including skeletal muscle, liver, adipose tissue, kidney, pancreas, heart, brain, and immune cells. Therapeutic strategies targeting this pathway aim at restoring normal homeostasis through dietary interventions, enzyme modulation, or pharmacological agents.
Modulation of enzyme activity (BCAT, BCKD) and metabolite levels (BCAAs, BCKAs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Branched-Chain Amino Acid Metabolism Pathway (BCAA Metabolism Pathway).